Neuro X is the title and theme for the May 1 symposium hosted by Johns Hopkins Institute for NanoBioTechnology. The event kicks off with a continental breakfast at 8 a.m. in the Owens Auditorium, between CRB I and CRB II on the Johns Hopkins University medical campus. Talks begin at 9 a.m. Posters featuring multidisciplinary research from across many Hopkins divisions and departments will be on display from 1 p.m. to 4 p.m.
One of this year’s speakers is Jordan J. Green, PhD.
Jordan Green is an associate professor in the Department of Biomedical Engineering at Johns Hopkins University. He graduated from Carnegie Mellon University with a bachelor’s degree in Biomedical Engineering, Chemical Engineering and then attended Massachusetts Institute of Technology to earn his doctorate in Biological Engineering. Green joined the Johns Hopkins faculty in 2008 His research focuses on cellular engineering and nanobiotechnology, with special interests in biomaterials, controlled drug delivery, and gene therapy. The potential of gene therapy and genetic medicine to benefit human health is tremendous as almost all human diseases have a genetic component, from cancer to cardiovascular disease. Methods for drug and gene delivery that are both safe and effective have remained elusive. New insights into understanding and controlling the mechanisms of delivery are required to further advance the field. To accomplish this, Green’s research team is developing a framework where biomaterials and nanoparticles can be rationally designed and computationally modeled. These same biomedical insights can also be used more broadly in the fields of regenerative medicine and nanomedicine.
Dr. Green is working at the chemistry/biology/engineering interface to answer fundamental scientific questions and create innovative technologies and therapeutics that can directly benefit human health. In 2014, Dr. Green was named one of Popular Science magazine’s “Brilliant Ten” list, highlighting young scientists who are revolutionizing their fields. He is also a member of the USA Science and Engineering Festival’s Nifty Fifty, which includes 200 of the most dynamic scientists and engineers in the United States who were selected for their unique ability to inspire the next generation of students to pursue careers in the STEM fields. He and Dr. Alfredo Quiñones-Hinojosa recently won a BioMaryland Center Biotechnology Development Award to advance their work on a biodegradable nanoparticle therapy enabling effective transfection of a patient’s stem cells derived from adipose tissue that are applied directly to the post-operative site of brain cancer.
Additional speakers will be profiled in the next few weeks. To register your poster and for more details visit http://inbt.jhu.edu/news/symposium/
For all press inquiries regarding INBT, its faculty and programs, contact Mary Spiro, firstname.lastname@example.org or 410-516-4802.